Shi L, Wen Z, Song Y, Wang J, Yu D
J Mol Graph Model. 2022; 117:108306.
PMID: 36063745
PMC: 9385381.
DOI: 10.1016/j.jmgm.2022.108306.
Thida M, Li B, Zhang X, Chen C, Zhang X
J Appl Biomed. 2021; 19(2):105-112.
PMID: 34907710
DOI: 10.32725/jab.2021.011.
Niinivehmas S, Pentikainen O
Molecules. 2021; 26(17).
PMID: 34500576
PMC: 8433903.
DOI: 10.3390/molecules26175142.
Bafna D, Ban F, Rennie P, Singh K, Cherkasov A
Int J Mol Sci. 2020; 21(12).
PMID: 32545494
PMC: 7352601.
DOI: 10.3390/ijms21124193.
Hu G, Li H, Xu S, Wang J
Int J Mol Sci. 2020; 21(6).
PMID: 32168940
PMC: 7139962.
DOI: 10.3390/ijms21061926.
Palladium-catalyzed coupling reactions on functionalized 2-trifluoromethyl-4-chromenone scaffolds. Synthesis of highly functionalized trifluoromethyl-heterocycles.
Izquierdo J, Jain A, Abdulkadir S, Schiltz G
Synthesis (Stuttg). 2019; 51(6):1342-1352.
PMID: 31274934
PMC: 6605783.
DOI: 10.1055/s-0037-1610669.
Network-Based Methods for Prediction of Drug-Target Interactions.
Wu Z, Li W, Liu G, Tang Y
Front Pharmacol. 2018; 9:1134.
PMID: 30356768
PMC: 6189482.
DOI: 10.3389/fphar.2018.01134.
In silico prediction of chemical mechanism of action via an improved network-based inference method.
Wu Z, Lu W, Wu D, Luo A, Bian H, Li J
Br J Pharmacol. 2016; 173(23):3372-3385.
PMID: 27646592
PMC: 5738663.
DOI: 10.1111/bph.13629.
Revealing the binding modes and the unbinding of 14-3-3σ proteins and inhibitors by computational methods.
Hu G, Cao Z, Xu S, Wang W, Wang J
Sci Rep. 2015; 5:16481.
PMID: 26568041
PMC: 4644958.
DOI: 10.1038/srep16481.
ROR nuclear receptors: structures, related diseases, and drug discovery.
Zhang Y, Luo X, Wu D, Xu Y
Acta Pharmacol Sin. 2014; 36(1):71-87.
PMID: 25500868
PMC: 4571318.
DOI: 10.1038/aps.2014.120.
Selective ligands of estrogen receptor β discovered using pharmacophore mapping and structure-based virtual screening.
Chen L, Wu D, Bian H, Kuang G, Jiang J, Li W
Acta Pharmacol Sin. 2014; 35(10):1333-41.
PMID: 25176400
PMC: 4186986.
DOI: 10.1038/aps.2014.69.
An in silico protocol for identifying mTOR inhibitors from natural products.
Chen L, Wang L, Gu Q, Xu J
Mol Divers. 2014; 18(4):841-52.
PMID: 25156384
DOI: 10.1007/s11030-014-9543-5.
Consensus Induced Fit Docking (cIFD): methodology, validation, and application to the discovery of novel Crm1 inhibitors.
Kalid O, Toledo Warshaviak D, Shechter S, Sherman W, Shacham S
J Comput Aided Mol Des. 2012; 26(11):1217-28.
PMID: 23053738
DOI: 10.1007/s10822-012-9611-9.
Derailed estrogen signaling and breast cancer: an authentic couple.
Manavathi B, Dey O, Gajulapalli V, Bhatia R, Bugide S, Kumar R
Endocr Rev. 2012; 34(1):1-32.
PMID: 22947396
PMC: 3565105.
DOI: 10.1210/er.2011-1057.
Thermal instability of ΔF508 cystic fibrosis transmembrane conductance regulator (CFTR) channel function: protection by single suppressor mutations and inhibiting channel activity.
Liu X, ODonnell N, Landstrom A, Skach W, Dawson D
Biochemistry. 2012; 51(25):5113-24.
PMID: 22680785
PMC: 3402225.
DOI: 10.1021/bi300018e.
Prediction of drug-target interactions and drug repositioning via network-based inference.
Cheng F, Liu C, Jiang J, Lu W, Li W, Liu G
PLoS Comput Biol. 2012; 8(5):e1002503.
PMID: 22589709
PMC: 3349722.
DOI: 10.1371/journal.pcbi.1002503.